Cited by 159T-cell and B-cell ImmunologyPsoriasis: Treatment and PathogenesisGenomics and Chromatin Dynamics

PU.1 Expression Delineates Heterogeneity in Primary Th2 Cells

Open access
Chang, Hua-Chen, Zhang, Shangming, Thieu, Vivian T., Slee, Roger B., Bruns, Heather A., Laribee, R. Nicholas, Klemsz, Michael J., Kaplan, Mark H.·2005·Immunity

Abstract

Primary T helper 2 cells are heterogeneous, expressing subsets of cytokines at varying levels. Mechanisms controlling this spectrum of phenotypes are still unclear. The ETS family transcription factor PU.1 is expressed in Th2 but not Th1 cells. Th2 cytokine production is decreased in cultures transduced with a PU.1-expressing retrovirus and increased in Th2 cells following RNAi that decreases PU.1 expression. In primary cultures, PU.1 expression is restricted to a subpopulation of Th2 cells that express CCL22 and a subset of Th2 cytokines. PU.1 regulates the Th2 phenotype by interfering with GATA-3 DNA binding without altering GATA-3 protein levels. Thus, the expression of PU.1 in subsets of Th2 cells establishes a defined cytokine profile and contributes towards establishing the spectrum of cytokine production observed in Th2 populations.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.immuni.2005.03.016

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PU.1 functions, at least in part, by limiting the ability of GATA-3 and IRF4 to interact with cytokine loci targets.

    “PU.1 functions, at least in part, by limiting the ability of GATA-3 and IRF4 to interact with cytokine loci targets7–9.”

    From The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation (2010) · cites this paper as [8]

    The Results report reduced GATA-3 binding to the IL-4 enhancer in IL-4-low Th2 cells, and the Discussion says PU.1 functions partly by interfering with GATA-3 DNA binding. The cited paper does not establish the corresponding claim about IRF4; a search for IRF4 and cytokine-locus targets found no supporting passage. Page numbers were not available in our copy. (LLM, conf=0.89)

    Experimental — accuracy not yet measured
  • Decreasing PU.1 expression or PU.1-deficiency increases overall cytokine production specifically in populations of cells that secrete two or more cytokines.

    “while shRNA that decreased PU.1 expression, or PU.1-deficiency, increased overall cytokine production specifically in populations of cells that secreted two or more cytokines7,8.”

    From The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation (2010) · cites this paper as [8]

    The Results section reports that PU.1 shRNA increased IL-4, IL-5, and IL-10 production, with the largest increases in cells positive for both IL-4 and IL-5 or both IL-4 and IL-10. But the same passage says the authors could not examine mature PU.1-deficient T cells; this paper therefore does not establish the deficiency part of the claim. (LLM, conf=0.90)

    Experimental — accuracy not yet measured
  • PU.1 appears to have distinct effects in various types of T cells: negatively regulating γδ T cell numbers, negatively regulating Th2 cytokine production and TCR expression, while promoting IL-9 expression.

    “Thus, PU.1 appears to have distinct effects in various types of T cells, negatively regulating γδ T cell numbers, negatively regulating Th2 cytokine production and TCR expression, while promoting IL-9 expression [15]–[17].”

    From The Transcription Factor PU.1 Regulates γδ T Cell Homeostasis (2011) · cites this paper as [16]

    The Results (page not provided) report that PU.1 expression decreased Th2 cytokines, including IL-4, IL-5, IL-10, and IL-13. Our copy does not establish the attributed effects on γδ T cell numbers, TCR expression, or IL-9 expression. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • PU.1 expression in T cells and subpopulations of Th2 cells contributes to heterogeneity in Th2 cytokine expression and TCR expression.

    “However the expression of PU.1 in T cells and subpopulations of Th2 cells contributes to heterogeneity in Th2 cytokine expression and TCR expression [16].”

    From The Transcription Factor PU.1 Regulates γδ T Cell Homeostasis (2011) · cites this paper as [16]

    The Results and Discussion (pages unavailable) show that PU.1 is expressed in a subset of Th2 cells and contributes to variation in their cytokine profiles. They do not show that PU.1 contributes to heterogeneity in TCR expression; the paper’s references to anti-CD3 stimulation do not establish that point. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • PU.1 is specifically expressed in subpopulations of TH2 cells that have low IL-4 expression.

    “PU.1 was specifically expressed in subpopulations of TH2 cells that had low IL-4 expression.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 50 · Cited by 159

Research works printed but not linked: 22

  1. [1]1. Abbas, A.K. ∙ Murphy, K.M. ∙ Sher, A. Functional diversity of helper T lymphocytes Nature. 1996; 383:787-793 Crossref Scopus (3948) PubMed Google Scholar
  2. [2]2. Agarwal, S. ∙ Rao, A. Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation Immunity. 1998; 9:765-775 Full Text Full Text (PDF) Scopus (621) PubMed Google Scholar
  3. [5]5. Avni, O. ∙ Lee, D. ∙ Macian, F. ... T(H) cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes Nat. Immunol. 2002; 3:643-651 Crossref PubMed Google Scholar
  4. [6]6. Bird, J.J. ∙ Brown, D.R. ∙ Mullen, A.C. ... Helper T cell differentiation is controlled by the cell cycle Immunity. 1998; 9:229-237 Full Text Full Text (PDF) Scopus (749) PubMed Google Scholar
  5. [7]7. Bruns, H.A. ∙ Schindler, U. ∙ Kaplan, M.H. Expression of a constitutively active stat6 in vivo alters lymphocyte homeostasis with distinct effects in T and B cells J. Immunol. 2003; 170:3478-3487 Crossref Scopus (60) PubMed Google Scholar
  6. [8]8. Bucy, R.P. ∙ Karr, L. ∙ Huang, G.-Q. ... Single cell analysis of cytokine coexpression during CD4+ T-cell phenotype development Proc. Natl. Acad. Sci. USA. 1995; 92:7565-7569 Crossref Scopus (123) PubMed Google Scholar
  7. [9]9. Chang, H.C. ∙ Zhang, S. ∙ Oldham, I. ... Stat4 requires the N-terminal domain for efficient phosphorylation J. Biol. Chem. 2003; 278:32471-32477 Full Text Full Text (PDF) Scopus (18) PubMed Google Scholar
  8. [10]10. Colucci, F. ∙ Samson, S.I. ∙ DeKoter, R.P. ... Differential requirement for the transcription factor PU.1 in the generation of natural killer cells versus B and T cells Blood. 2001; 97:2625-2632 Crossref Scopus (110) PubMed Google Scholar
  9. [11]11. Dahl, R. ∙ Ramirez-Bergeron, D.L. ∙ Rao, S. ... Spi-B can functionally replace PU.1 in myeloid but not lymphoid development EMBO J. 2002; 21:2220-2230 Crossref Scopus (39) PubMed Google Scholar
  10. [12]12. DeKoter, R.P. ∙ Singh, H. Regulation of B lymphocyte and macrophage development by graded expression of PU.1 Science. 2000; 288:1439-1441 Crossref Scopus (585) PubMed Google Scholar
  11. [13]13. DeKoter, R.P. ∙ Lee, H.J. ∙ Singh, H. PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors Immunity. 2002; 16:297-309 Full Text Full Text (PDF) Scopus (251) PubMed Google Scholar
  12. [14]14. Farrar, J.D. ∙ Ouyang, W. ∙ Lohning, M. ... An instructive component in T helper cell type 2 (Th2) development mediated by GATA-3 J. Exp. Med. 2001; 193:643-650 Crossref Scopus (90) PubMed Google Scholar
  13. [16]16. Glimcher, L.H. ∙ Murphy, K.M. Lineage commitment in the immune system: the T helper cell grows up Genes Dev. 2000; 14:1693-1711 Crossref PubMed Google Scholar
  14. [17]17. Gourley, T. ∙ Roys, S. ∙ Lukacs, N.W. ... A novel role for the major histocompatibility complex class II transactivator CIITA in the repression of IL-4 production Immunity. 1999; 10:377-386 Full Text Full Text (PDF) Scopus (74) PubMed Google Scholar
  15. [18]18. Guo, L. ∙ Hu-Li, J. ∙ Zhu, J. ... In TH2 cells the Il4 gene has a series of accessibility states associated with distinctive probabilities of IL-4 production Proc. Natl. Acad. Sci. USA. 2002; 99:10623-10628 Crossref Scopus (73) PubMed Google Scholar
  16. [19]19. Guo, L. ∙ Hu-Li, J. ∙ Paul, W.E. Probabilistic regulation of IL-4 production in Th2 cells: accessibility at the Il4 locus Immunity. 2004; 20:193-203 Full Text Full Text (PDF) Scopus (61) PubMed Google Scholar
  17. [20]20. Henkel, G. ∙ Brown, M.A. PU.1 and GATA: components of a mast cell-specific interleukin 4 intronic enhancer Proc. Natl. Acad. Sci. USA. 1994; 91:7737-7741 Crossref Scopus (121) PubMed Google Scholar
  18. [21]21. Jankovic, D. ∙ Kullberg, M.C. ∙ Noben-Trauth, N. ... Single cell analysis reveals that IL-4 receptor/Stat6 signaling is not required for the in vivo or in vitro development of CD4+ lymphocytes with a Th2 cytokine profile J. Immunol. 2000; 164:3047-3055 Crossref Scopus (208) PubMed Google Scholar
  19. [22]22. Kaplan, M.H. ∙ Schindler, U. ∙ Smiley, S.T. ... Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells Immunity. 1996; 4:313-319 Full Text Full Text (PDF) Scopus (1382) PubMed Google Scholar
  20. [23]23. Kaplan, M.H. ∙ Sun, Y.-L. ∙ Hoey, T. ... Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice Nature. 1996; 382:174-177 Crossref Scopus (1078) PubMed Google Scholar
  21. [24]24. Karulin, A.Y. ∙ Hesse, M.D. ∙ Tary-Lehmann, M. ... Single-cytokine-producing CD4 memory cells predominate in Type 1 and Type 2 immunity J. Immunol. 2000; 164:1862-1872 Crossref Scopus (157) PubMed Google Scholar
  22. [25]25. Klemsz, M.J. ∙ McKercher, S.R. ∙ Celada, A. ... The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene Cell. 1990; 61:113-124

Authors
Chang, H.-C., Zhang, S., Thieu, V. T., Slee, R. B., Bruns, H. A., Laribee, R. N., Klemsz, M. J., & Kaplan, M. H.
Affiliations
Walther Cancer Foundation (US)
Corresponding author
Kaplan, Mark H.
Venue
Immunity
Publisher
Elsevier BV
Published
2005-06
Volume
22
Issue
6
Pages
693-703
ISSN
1074-7613 (ISSN-L)
OpenAlex
W2056835764
Cited by
159
References
50
Citations by year
2026: 1 · 2025: 3 · 2024: 7 · 2023: 8 · 2022: 4 · 2021: 4 · 2020: 9 · 2019: 5 · 2018: 10 · 2017: 8 · 2016: 7 · 2015: 12 · 2014: 6 · 2013: 16 · 2012: 7
FWCI
2.02
Type
journal article
Language
en
Open access
Locations
  • Immunity (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institute of Allergy and Infectious Diseases (AI-45515, AI57459, R01AI057459)
  • National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007519, DK007519)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords
PU.1, Th2 cells, cytokine production, GATA3, CCL22, ETS transcription factors, transcriptional regulation, primary T cells
MeSH terms
Proto-Oncogene Protein Spi-1, Animals, Cells, Cultured, DNA-Binding Proteins, Female, Flow Cytometry, Mice, Inbred BALB C, Phenotype, Proto-Oncogene Proteins, Retroviridae, Blotting, Northern, Blotting, Western, Trans-Activators, Cytokines, Th1 Cells, Th2 Cells, Reverse Transcriptase Polymerase Chain Reaction, RNA Interference, Immunoprecipitation, GATA3 Transcription Factor, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review